BR9608067A - Composição terapêutica compreendendo um antígeno ou um gerador in vivo de um composto que compreende uma sequência de ácidos aminados - Google Patents

Composição terapêutica compreendendo um antígeno ou um gerador in vivo de um composto que compreende uma sequência de ácidos aminados

Info

Publication number
BR9608067A
BR9608067A BR9608067A BR9608067A BR9608067A BR 9608067 A BR9608067 A BR 9608067A BR 9608067 A BR9608067 A BR 9608067A BR 9608067 A BR9608067 A BR 9608067A BR 9608067 A BR9608067 A BR 9608067A
Authority
BR
Brazil
Prior art keywords
antigen
compound
amino acid
acid sequence
therapeutic composition
Prior art date
Application number
BR9608067A
Other languages
English (en)
Inventor
Vincent Ganne
Original Assignee
Seppic Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seppic Sa filed Critical Seppic Sa
Publication of BR9608067A publication Critical patent/BR9608067A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9608067A 1995-04-20 1996-04-22 Composição terapêutica compreendendo um antígeno ou um gerador in vivo de um composto que compreende uma sequência de ácidos aminados BR9608067A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9504739A FR2733151B1 (fr) 1995-04-20 1995-04-20 Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
PCT/FR1996/000609 WO1996032964A1 (fr) 1995-04-20 1996-04-22 Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines

Publications (1)

Publication Number Publication Date
BR9608067A true BR9608067A (pt) 1999-01-26

Family

ID=9478297

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608067A BR9608067A (pt) 1995-04-20 1996-04-22 Composição terapêutica compreendendo um antígeno ou um gerador in vivo de um composto que compreende uma sequência de ácidos aminados

Country Status (12)

Country Link
US (5) US6274149B1 (pt)
EP (1) EP0825875B1 (pt)
JP (2) JP3455226B2 (pt)
KR (1) KR19990007883A (pt)
CN (1) CN1088599C (pt)
AU (1) AU695802B2 (pt)
BR (1) BR9608067A (pt)
DE (1) DE69608962T2 (pt)
ES (1) ES2147924T3 (pt)
FR (1) FR2733151B1 (pt)
NO (1) NO974837D0 (pt)
WO (1) WO1996032964A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (fr) * 1993-07-22 1995-09-01 Chemoxal Sa Procédé de traitement d'un article et nouvelle solution aqueuse de peroxyde d'hydrogène.
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
US6689370B1 (en) * 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
EP1195162B1 (en) * 1999-03-03 2008-06-04 The Kitasato Institute Vaccine preparation containing fatty acid as a constituent
FR2800280B1 (fr) * 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
KR20000024614A (ko) * 2000-02-23 2000-05-06 이기창 휴대 전화기와 음향기기를 함께 사용할 수 있는 스테레오핸즈프리 송수화기 및 전환 제어장치
FR2809961B1 (fr) * 2000-06-09 2004-12-03 Seppic Sa Utilisation d'ethers de sucres, comme adjuvants d'immunite dans les compositions vaccinales, compositions therapeutiques les renfermant et leur utilisation comme vaccins
AU2001280208A1 (en) 2000-08-31 2002-03-13 The Kitasato Institute Vaccine preparation containing fatty acid as component
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
WO2002028424A2 (en) * 2000-10-06 2002-04-11 Paradies H Henrich Kyberdrug as autovaccines with immune-regulating effects
WO2002069985A2 (en) * 2001-03-05 2002-09-12 Forinnova As Immune response potentiation
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
AU2004226591B2 (en) * 2003-04-04 2009-06-04 Zoetis Services Llc Microfluidized oil-in-water emulsions and vaccine compositions
JP2005075752A (ja) * 2003-08-29 2005-03-24 Nippon Inst For Biological Science 豚繁殖・呼吸障害症候群用ワクチン製剤
DE10351644A1 (de) * 2003-11-05 2005-06-09 Bayer Technology Services Gmbh Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
FR2955776A1 (fr) 2010-02-01 2011-08-05 Seppic Sa Utilisation d'une huile minerale specifique pour la fabrication d'un nouveau adjuvant
FR2955775B1 (fr) 2010-02-01 2012-05-04 Seppic Sa Adjuvant pour la preparation de compositions vaccinales destinees a la prevention contre les coccidioses
FR2956403B1 (fr) 2010-02-17 2014-10-17 Afssa Antigenes polypeptidiques de trichinella, et leurs applications
US20170080084A1 (en) * 2014-03-17 2017-03-23 Glaxosmithkline Biologicals Sa Oil/surfactant mixtures for self-emulsification
US10881722B2 (en) 2016-09-20 2021-01-05 Kansas State University Research Foundation Epizootic hemorrhagic disease vaccine
CN108324940B (zh) * 2018-03-19 2020-07-07 中国医学科学院医学生物学研究所 甘油-3-磷酸的应用、含有甘油-3-磷酸的佐剂和疫苗剂
CN111658611B (zh) * 2020-04-13 2021-06-01 四川大学 一种基于微乳的疫苗递送系统及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925544A (en) * 1971-07-12 1975-12-09 Univ Southern Illinois Bovine vaccines and methods of making and using same
US4186194A (en) 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
US4720386A (en) * 1976-11-24 1988-01-19 Mccollester Duncan L Vaccine and method for immunotherapy of neoplastic disease
LU77364A1 (pt) * 1977-05-18 1979-01-19
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
DE3416609A1 (de) * 1984-05-05 1985-11-07 Degussa Ag, 6000 Frankfurt 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten
US4746742A (en) * 1985-11-28 1988-05-24 Toho Yakuhin Kogyo Kabushiki Kaisha Analogs of nonreducing monosaccharide moiety of lipid A
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US4976954A (en) 1986-12-02 1990-12-11 Purdue Research Foundation Anticariogenic compositions
FR2619718B1 (fr) 1987-09-02 1991-07-12 Medibrevex Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
FR2649013B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
US5393791A (en) 1990-07-19 1995-02-28 Helena Chemical Company Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
FR2672495B1 (fr) * 1991-02-08 1995-10-20 Vacsyn France Sa Compositions immunomodulatrices, a base de produits comportant au moins un groupe phosphate ou sulfate, et un gel d'un compose d'aluminium.
FR2674755B1 (fr) * 1991-04-05 1995-02-03 Thorel Jean Noel Nouvelles compositions medicamenteuses immunostimulatrices.
WO1992018147A1 (en) 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
US5656465A (en) 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US5690942A (en) 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines

Also Published As

Publication number Publication date
AU695802B2 (en) 1998-08-20
US6342234B1 (en) 2002-01-29
ES2147924T3 (es) 2000-10-01
US6274149B1 (en) 2001-08-14
FR2733151A1 (fr) 1996-10-25
US6610309B2 (en) 2003-08-26
JPH11503743A (ja) 1999-03-30
CN1088599C (zh) 2002-08-07
CN1184431A (zh) 1998-06-10
KR19990007883A (ko) 1999-01-25
US6251407B1 (en) 2001-06-26
US20020164359A1 (en) 2002-11-07
EP0825875A1 (fr) 1998-03-04
EP0825875B1 (fr) 2000-06-21
NO974837L (no) 1997-10-20
JP3455226B2 (ja) 2003-10-14
FR2733151B1 (fr) 1997-05-23
JP2002193841A (ja) 2002-07-10
DE69608962T2 (de) 2000-11-16
NO974837D0 (no) 1997-10-20
DE69608962D1 (de) 2000-07-27
AU5696896A (en) 1996-11-07
US20010033845A1 (en) 2001-10-25
WO1996032964A1 (fr) 1996-10-24

Similar Documents

Publication Publication Date Title
AU5696896A (en) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FI972945A7 (fi) Antigeenien antamiseen soveltuvia koostumuksia
BR9607791A (pt) Formulação oral de 2-metil-tieno-benzodiazepina
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
FI974395L (fi) Menetelmät ja koostumukset sidekudoskiinnityksen parantamiseksi ja korjaamiseksi
FI962154L (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
EP0804459A4 (en) THERAPEUTIC CONNECTIONS
EE03424B1 (et) Allergiavastase valguhüdrolüsaadipreparaadi valmistamise meetod
BR9611137A (pt) Composições e métodos para distribuição bucal de agentes farmacêuticos
NO307408B1 (no) Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev
FI970298L (fi) DHA:n käyttö farmaseuttisena koostumuksena
HUP9902136A3 (en) Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
EP1011621A4 (en) METHOD AND COMPOSITIONS FOR WHITENING TEETH
PT1275387E (pt) Processo de preparacao de composicoes farmaceuticas de fenofibrato apresentando uma biodisponibilidade elevada
FR2745174B1 (fr) Composition cosmetique de fixation et de brillance
FI963679L (fi) Stabiloitu koostumus peptidien antamiseksi suun kautta
FI972744L (fi) Aminohappokokoonpanoja ja niiden käyttö kliinisessä ravinnossa
BR9610821A (pt) Derivado de aminoácido uso de um composto e medicamento contendo o mesmo
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
FI952297L (fi) Fluoridia vapauttava hammaspohjustekoostumus ja menetelmä sen käyttämiseksi
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
NO991175L (no) Anvendelse av proteiner som midler mot autoimmune sykdommer
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/09/2007, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 14A E 15A ANUIDADE(S).

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO DESPACHO 24.3 PUBLICADO NA RPI 2113 DE 05/07/2011.